The S&P 500 finished at 7,719.34, failing to hold its previous week's momentum despite a late-session rally. Market focus remained fixed on a narrow leadership group, leaving the Dow Jones Industrial Average to close the week down 1.42% at 51,094.96. Rising interest rates played a role in the broader cooling, with the 10-year Treasury yield climbing 8 basis points over the week to reach 5.26%.

Corporate developments underscored a week of mixed performance. RTX secured a significant $24.4 billion contract for Standard Missile-6 interceptors, while Integra LifeSciences lowered its full-year guidance following flood-related disruptions at its Cincinnati facility. Meanwhile, Axogen signaled a shift in its growth strategy by acquiring BioCircuit Technologies, adding the sutureless nerve repair device NerveTape to its portfolio. Elsewhere, Phillips Edison & Company reaffirmed its 2026 earnings outlook, even as it ramped up its acquisition targets to as much as $700 million.